Abe Masahiro, Koizumi Ami, Umeyama Takashi, Tomuro Hiroko, Muraosa Yasunori, Nakayama Nobuko, Oiki Sayoko, Shimada Satoshi, Murakami Yuko, Ota Masayuki, Yoshimi Itsuro, Takahashi Azusa, Ono Takashi, Sasaki Masaru, Uchida-Fujii Eri, Nakashita Manami, Kurosu Hitomi, Yamagishi Takuya, Shinohara Takayuki, Hoshino Yasutaka, Miyazaki Yoshitsugu
Department of Fungal Infection, National Institute of Infectious Diseases, Japan.
Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Japan.
Jpn J Infect Dis. 2025 Mar 31. doi: 10.7883/yoken.JJID.2025.025.
Candida auris (C. auris) was initially isolated from a Japanese patient, and this species is an emerging fungus nowadays owing to its long-term colonization capabilities and high resistance to antifungal drugs. However, accurate domestic epidemiology of C. auris remains unknown. We here collected C. auris isolates reported from hospitals, public health centers, and public health institutes based on the administrative liaison. Moreover, we collected stocked C. auris isolates from three nongovernmental laboratory companies. Seventy C. auris isolates were collected during the study period. C. auris isolates predominantly originated from ear discharge clinical samples. Clade determination based on ITS-D1/D2 regions and CauMT1 locus revealed that almost all isolates belonged to clade II; however, one ear discharge-derived isolate belonged to clade I. Whole genome sequencing also confirmed this clade I C. auris isolate. Regarding drug susceptibilities, 20% of isolates were resistant to fluconazole; however, no isolates exhibited polyene or echinocandin resistance. Therefore, C. auris isolates in Japan were generally derived from ear discharges and belonged to clade II. However, ear discharge-derived isolates may not exclusively belong to clade II. Although no invasive cases were reported during the study period, continuing surveillance program for describing clear domestic epidemiology would be necessary.
耳念珠菌最初是从一名日本患者身上分离出来的,由于其长期定植能力和对抗真菌药物的高抗性,该菌种如今已成为一种新兴真菌。然而,国内耳念珠菌的确切流行病学情况仍不为人知。我们在此通过行政联络收集了医院、公共卫生中心和公共卫生机构报告的耳念珠菌分离株。此外,我们还从三家非政府实验室公司收集了储存的耳念珠菌分离株。在研究期间共收集到70株耳念珠菌分离株。耳念珠菌分离株主要来源于耳分泌物临床样本。基于ITS-D1/D2区域和CauMT1基因座的进化枝测定显示,几乎所有分离株都属于进化枝II;然而,一株来源于耳分泌物的分离株属于进化枝I。全基因组测序也证实了这株进化枝I的耳念珠菌分离株。关于药敏性,20%的分离株对氟康唑耐药;然而,没有分离株表现出对多烯类或棘白菌素类药物耐药。因此,日本的耳念珠菌分离株一般来源于耳分泌物,且属于进化枝II。然而,来源于耳分泌物的分离株可能并不都属于进化枝II。尽管在研究期间没有报告侵袭性病例,但仍有必要持续开展监测计划以明确国内的流行病学情况。